The number of individuals in the UK that are currently using e-cigarettes as an alternative to smoking tobacco cigarettes is close to 2.9 million, many of whom have turned to alternatives in an attempt to quit smoking. While they can certainly help people kick the habit, there is currently still a big debate surrounding e-cigarettes, as there seems to be contradicting evidence as to whether they are safe or not.

“Tobacco (cigarettes and other forms of tobacco) are strong agents that could cause cancer (carcinogens) with a global impact. A tobacco research study includes knowledge, perceptions, attitudes and behavioural patterns of people who smoke tobacco products or e-cigarettes to help users and manufacturers understand the risks involved. Results of these studies are needed to support the need for greater create awareness around the use of tobacco products, as well as the need for adequate regulation of these products,”

This, according to Sophie Notley, who is a researcher from CSURES - a global leader on behavioural science in tobacco harm reduction. She added by saying that in order to achieve the Sustainable Development Goal of a substantial reduction in premature deaths due to non-communicable diseases by 2030, tobacco control should become a priority in all countries.

To generate data on the dangers of nicotine, as well as flavouring agents, and syrups used in e-cigarettes, it is necessary to conduct research, through tests and behavioural patterns. Research agencies such as CSURES focus strongly on tobacco harm reduction and assessing the public health impact of Electronic Nicotine Delivery Systems (ENDS).

CSURES offer a wide range of services ranging from research programme design to analytical services, presentation of research findings and assistance with regulatory submission by tobacco product manufacturers. Their staff members aim to ensure the use of high-quality behavioural research by those working in tobacco industries, and their own goals are to reduce the harms associated with the use of tobacco products.

With over 20 years of experience in the industry, CSURES has gained a stellar reputation and they are known as a trusted and reliable research consultant agency, and a leader in behavioural science in tobacco harm reduction. They offer many areas of research expertise that include many regulatory-related behavioural science studies which have been designed and performed by them for some of the largest manufacturers within the tobacco harm reduction ENDS space.

More information on this can also be found on their information-packed website, or you can send them an email if you have any further enquiries.

About us: CSUR is a Global Leader on Behavioural Science in Tobacco Harm Reduction, operating from their base at the Centre for Substance Use Research Ltd in Glasgow. CSUR opened in 1994 linked initially to the University of Glasgow, and in 2011 CSUR became a wholly independent research centre focussing on a wider range of substance use issues and developing a large programme of behaviourally focussed regulatory science research assessing the contribution of ENDS in reducing tobacco-related health harm. Our team comprises post-doctoral researchers in behavioural science, experts in marketing, cybersecurity, and media. Our focus is on furthering the goals of tobacco-related harm reduction and assessing the public health impact of Electronic Nicotine Delivery Systems (ENDS) and our goal is to ensure that those working within these industries have access to high-quality behavioural research that can further their owns goals of reducing the harms associated with the use of combustible tobacco products. Find out more by visiting our website at https://www.csures.com.